Revised SPCs: Revestive (teduglutide) solution for injection – all strengths

SPC updated to warn patients with short bowel syndrome (SBS) are susceptible to dehydration that may lead to acute renal failure. Teduglutide is licensed for treatment of patients > 1 years old with SBS.

Source:

electronic Medicines compendium